Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential by Peddi, Parvin F., Hurvitz, Sara A.

Request full text

Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer by Peddi, Parvin F, Fasching, Peter A, Liu, Duan, Quinaux, Emmanuel, Robert, Nicholas J, Valero, Vicente, Crown, John, Falkson, Carla, Brufsky, Adam, Cunningham, Julie M, Weinshilboum, Richard M, Pienkowski, Tadeusz, Eiermann, Wolfgang, Martín, Miguel, Bee, Valerie, Wang, Xiaoyan, Wang, Liewei, Yang, Eric, Slamon, Dennis J, Hurvitz, Sara A

Get full text

Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma by Cho, May, Peddi, Parvin F, Ding, Kevin, Chen, Ling, Thomas, Denise, Wang, Jian, Lockhart, Albert C, Tan, Benjamin, Wang-Gillam, Andrea

Get full text

Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy by Peddi, Parvin F., Ma, Cynthia X., Ellis, Matthew J.

Get full text

Fertility after breast cancer treatment by Kasum, Miro, Beketić-Orešković, Lidija, Peddi, Parvin F, Orešković, Slavko, Johnson, Rebecca H

Get full text

Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer by Peddi, Parvin F, Shatsky, Rebecca A, Hurvitz, Sara A

Get full text

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer by Peddi, Parvin F., Hurvitz, Sara A.

Get full text

A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer by Wainberg, Zev A, Messersmith, Wells A, Peddi, Parvin F, Kapp, Amy V, Ashkenazi, Avi, Royer-Joo, Stephanie, Portera, Chia C, Kozloff, Mark F

Get full text

Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus by Peddi, Parvin F., Tetef, Merry, Coluzzi, Paul, Arzoo, Karo K., Hu, Eddie H., Berkowitz, Maurice J., Chan, David, Moore, Dennis, Adams, Brad, Wang, Xiaoyan, Hurvitz, Sara A.

Get full text

Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma by Peddi, Parvin F, Cho, May, Wang, Jian, Gao, Feng, Wang-Gillam, Andrea

Get full text

Abstract OT1-18-03: The neoIRX trial:locoregional cytokine therapy to promote immunologic priming and enhanced response to neoadjuvant pembrolizumab plus chemotherapy in triple neg... by Sanchez, Katherine, Conlin, Alison, Peddi, Parvin, Stanton, Sasha, Ruzich, Janet, Perlewitz, Kelly, Wu, Yaping, Moxon, Nicole, Mellinger, Staci, Sun, Zhaoyu, Redmond, William, Page, David B

Get full text

PARP Inhibitors in Breast Cancer: Latest Evidence by Ponec, Ryan M., Peddi, Parvin, Callahan, Rena D.

Get full text

Engaging Oncologists Toward Integrating a Shared Mental Model (SMM) for Palliative Oncology within a Large Academic Oncology Practice (TH341B) by Walling, Anne, Coscarelli, Anne, Simon, Wendy, Wenger, Neil, Pietras, Christopher, Ahmed, Kauser, Hurvitz, Sara A., Phung, Peter, Nechrebecki, Meghan, DAmbruoso, Sarah F., Kung, Jennie, Goldman, Jonathan Wade, Rosen, Lee S., Drakaki, Alexandra, Peddi, Parvin F., Lee Wong, Deborah Jean, Glaspy, John A.

Get full text

Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study by Kalra, Maitri, Henry, Elizabeth, McCann, Kelly, Karuturi, Meghan S, Bustamante Alvarez, Jean G, Parkes, Amanda, Wesolowski, Robert, Wei, Mei, Mougalian, Sarah S, Durm, Gregory, Qin, Angel, Schonewolf, Caitlin, Trivedi, Meghna, Armaghani, Avan J, Wilson, Frederick H, Iams, Wade T, Turk, Anita A, Vikas, Praveen, Cecchini, Michael, Lubner, Sam, Pathak, Priyadarshini, Spencer, Kristen, Koshkin, Vadim S, Labriola, Matthew K, Marshall, Catherine H, Beckermann, Katy E, Sharifi, Marina N, Bejjani, Anthony C, Hotchandani, Varsha, Housri, Samir, Housri, Nadine

Get full text